Home » Topics » Diagnostics, BioWorld Science

Diagnostics, BioWorld Science
RSS

Navidea reports further phase IIb data on Tc99m tilmanocept imaging for rheumatoid arthritis

Nov. 13, 2020

[124I]-RmAb158-scFv8D3 detects soluble Abeta changes following treatment

Nov. 13, 2020

[64Cu]DOTA-UBI 29-41 for imaging of active infectious processes

Nov. 11, 2020

[125I]PIB-Ec1 as promising tracer for imaging EpCAM expression in ovarian cancer

Nov. 10, 2020

Preclinical characterization of [99mTc]Tc-TECANT-1

Nov. 10, 2020

[18F]AS3504073-00: a PET tracer for imaging mitochondrial fatty acid beta-oxidation in the heart

Nov. 6, 2020

[64Cu]PSMA I&T shows promise for PSMA-specific PET imaging

Nov. 6, 2020

[18F]FSU-880 imaging evaluated in prostate cancer patients with biochemical recurrence

Nov. 5, 2020

[68Ga]Desferal developed for imaging of bacterial infections

Nov. 5, 2020

Preliminary first-in-human data for [11C]MeDAS PET tracer

Nov. 5, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...